63 related articles for article (PubMed ID: 23426717)
1. Aberrant production of soluble inducible T-cell co-stimulator (sICOS) and soluble programmed cell death protein 1 (sPD-1) in patients with chronic hepatitis C.
Wang D; Zhou D; Du Q; Liang Q; Wang Q; Fang L; Wang G; Fan Q; Liu B; Zhou J; Tang Z; Wu H; Guo X; Jiao Y; Zhang G
Mol Med Rep; 2013 Apr; 7(4):1197-202. PubMed ID: 23426717
[TBL] [Abstract][Full Text] [Related]
2. Aberrant production of soluble inducible T cell co‑stimulator and soluble programmed cell death protein 1 in patients with chronic hepatitis B.
Wang D; Du Q; Luo G; Wang Q; Wang G; Zhang G; Leng Z; Guo X
Mol Med Rep; 2017 Dec; 16(6):8556-8562. PubMed ID: 28983583
[TBL] [Abstract][Full Text] [Related]
3. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
[TBL] [Abstract][Full Text] [Related]
4. Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosis.
Yanaba K; Asano Y; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Arch Dermatol Res; 2013 Jan; 305(1):17-23. PubMed ID: 23053221
[TBL] [Abstract][Full Text] [Related]
5. Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration.
Yu H; Zou X; Peng L; Wang Y; Zhang C; Chen B; Zou Y
DNA Cell Biol; 2013 Dec; 32(12):717-21. PubMed ID: 24083358
[TBL] [Abstract][Full Text] [Related]
6. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
[TBL] [Abstract][Full Text] [Related]
7. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
[TBL] [Abstract][Full Text] [Related]
8. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
[TBL] [Abstract][Full Text] [Related]
9. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
[TBL] [Abstract][Full Text] [Related]
10. HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury.
Adinolfi LE; Andreana A; Utili R; Zampino R; Ragone E; Ruggiero G
Am J Gastroenterol; 1998 Nov; 93(11):2162-6. PubMed ID: 9820390
[TBL] [Abstract][Full Text] [Related]
11. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
12. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
[TBL] [Abstract][Full Text] [Related]
13. Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients.
Rahbin N; Frelin L; Aleman S; Hultcrantz R; Sällberg M; Brenndörfer ED
Biochem Biophys Res Commun; 2013 Mar; 433(1):31-5. PubMed ID: 23454379
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.
Riezu-Boj JI; Larrea E; Aldabe R; Guembe L; Casares N; Galeano E; Echeverria I; Sarobe P; Herrero I; Sangro B; Prieto J; Lasarte JJ
J Hepatol; 2011 Mar; 54(3):422-31. PubMed ID: 21129807
[TBL] [Abstract][Full Text] [Related]
15. Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.
Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
Hepatology; 2008 Jul; 48(1):80-7. PubMed ID: 18571785
[TBL] [Abstract][Full Text] [Related]
16. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
Schirren CA; Jung MC; Gerlach JT; Worzfeld T; Baretton G; Mamin M; Hubert Gruener N; Houghton M; Pape GR
Hepatology; 2000 Sep; 32(3):597-603. PubMed ID: 10960455
[TBL] [Abstract][Full Text] [Related]
17. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
19. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
20. Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients.
Lau DT; Fish PM; Sinha M; Owen DM; Lemon SM; Gale M
Hepatology; 2008 Mar; 47(3):799-809. PubMed ID: 18203148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
